{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/60518a52f69aa815d2dba41c/69dd427d3472e03bc70d4040?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Lawfare Daily: Sam Altman with Ronan Farrow and Andrew Marantz","description":"<p>Senior Editor Kate Klonick interviews reporters Ronan Farrow and Andrew Marantz on their recent article in the New Yorker, titled&nbsp;“<a href=\"https://www.newyorker.com/magazine/2026/04/13/sam-altman-may-control-our-future-can-he-be-trusted\" rel=\"noopener noreferrer\" target=\"_blank\">Sam Altman May Control Our Future—Can He Be Trusted?</a>”<em>&nbsp;</em>In their 16,000-word piece, Farrow and Marantz create a cohesive narrative with receipts around Sam Altman, the products he's building at OpenAI, and how he's selling them not just to investors and the public, but also to regulators and world leaders.</p><p>Klonick unpacks three key areas that are discussed in the piece: potential concerns of fraud, ongoing trust and safety and alignment issues at OpenAI, and the national security concerns that the article exposes in the \"country plan\" and Altman's entanglements in the Gulf. The discussion ends with a basic question: Are any of these legal issues enough to stop or correct the course of OpenAI, with its estimated $1T IPO in the coming weeks?</p><p>To receive ad-free podcasts, become a&nbsp;<em>Lawfare&nbsp;</em>Material Supporter at&nbsp;<a href=\"http://www.patreon.com/lawfare\" rel=\"noopener noreferrer\" target=\"_blank\">www.patreon.com/lawfare</a>. You can also support&nbsp;<em>Lawfare&nbsp;</em>by making a one-time donation at&nbsp;<a href=\"https://givebutter.com/lawfare-institute\" rel=\"noopener noreferrer\" target=\"_blank\">https://givebutter.com/lawfare-institute</a>.</p>","author_name":"The Lawfare Institute"}